Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation

American Journal of Transplantation

Volumn 13, Issue 10, 2013, Pages 2739-2742

  Elias, N ^a   Kawai, T ^a   Ko, D S C ^a   Saidi, R ^a   Tolkoff Rubin, N ^a   Wicky, S ^a   Cosimi, A B ^a   Hertl, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Auxiliary liver transplantation; combined transplants; graft function; hyperoxaluria; hypertrophy; partial liver grafts

Indexed keywords

CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXALIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; AUXILIARY PARTIAL LIVER TRANSPLANTATION; BRAIN DEATH; CASE REPORT; COLD ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; FOLLOW UP; FUNCTIONAL STATUS; HEAD INJURY; HEMODIALYSIS; HEPATIC ARTERY; HUMAN; ILIAC ARTERY; IMMUNOSUPPRESSIVE TREATMENT; INFERIOR CAVA VEIN; KIDNEY; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER VEIN; MALE; MORBIDITY; NEPHRECTOMY; OXALOSIS 1; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN EMBOLIZATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; SEROLOGY;

AUXILIARY LIVER TRANSPLANTATION; COMBINED TRANSPLANTS; GRAFT FUNCTION; HYPEROXALURIA; HYPERTROPHY; PARTIAL LIVER GRAFTS;

ADULT; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; OXALATES; PORTAL VEIN; PROGNOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84884905837     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12381     Document Type: Article

References (9)

1. Cochat P., Primary hyperoxaluria type 1. Kidney Int 1999; 55: 2533-2547.
2. Harambat J, Fargue S, Acquaviva C, et al. Genotype-phenotype correlation in primary hyperoxaluria type 1: The p. Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 2010; 77: 443-449.
3. Broyer M, Brunner FP, Brynger H, et al. Kidney transplantation in primaryoxalosis: Data from the EDTA Registry. Nephrol Dial Transplant 1990; 5: 332-336.
4. Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU., Renal allograft survival in patientswith oxalosis. Transplantation 2002; 74: 707-710.
5. Perera MT, Sharif K, Lloyd C, et al. Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration. Nephrol Dial Transplant 2011; 26: 354-359.
6. Onaca N, Sanchez EQ, Melton LB, et al. Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation. 2005; 80: 421-424.
7. Bergstralh EJ, Monico CG, Lieske JC, et al. Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2010; 10: 2493-2501.
8. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990; 107: 521-527.
9. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: A meta-analysis. Ann Surg 2008; 247: 49-57.